"The research published today describes GAIM, NeuroPhage's unique approach to treat diseases characterized by misfolded proteins. GAIM has the potential to provide a more robust response than previous therapies because it enables the simultaneous targeting of multiple pathologies within a single disease," said Dr. Richard Fisher, Chief Scientific Officer at NeuroPhage.

This novel and revolutionary approach was published online in the Journal of Molecular Biology. The publication, "A bacteriophage capsid protein provides a general amyloid interaction motif (GAIM) that binds and remodels misfolded protein assemblies," was authored by Rajaraman Krishnan et al. For more information, Click Here.

"Symptoms of neurodegenerative diseases often appear well after the troublesome aggregates have begun to accumulate in the brain. By then, therapies that only target newly forming aggregates are likely to only slow the progression of the disease and are believed to be too late once the aggregates are formed," said Dr. Gregory A. Petsko, Professor of Neurology at Weill Cornell Medical College in New York City, and Tauber Professor of Biochemistry and Chemistry, Emeritus, at Brandeis University in Waltham, Massachusetts.

"Therapies based on GAIM would represent a completely new paradigm in the treatment of many neurodegenerative diseases with their potential to ameliorate existing symptoms and prevent disease progression. The hope is this will eventually lead to a real treatment for Alzheimer's disease, but for now, the science behind it is quite compelling."

Researchers used an array of techniques, including X-ray fiber diffraction and nuclear magnetic resonance spectroscopy, to demonstrate the activities of GAIM. They discovered that GAIM effectively binds to multiple types of misfolded proteins during their formation in such a way that prevents new toxic protein aggregates from forming. In addition, upon incubating GAIM with various misfolded proteins, the researchers observed that GAIM disrupted these assemblies of misfolded proteins by causing a conformational change in their structures. This structural change could enable the body's natural disposal mechanism to recognize and clear the misfolded proteins, which in theory, would enable the brain to return to a more normal state. The ability to destabilize pre-existing aggregates of multiple types of misfolded proteins is unique in the field.

The discovery of GAIM has led to the creation of NeuroPhage's lead candidate, NPT088, which is the GAIM motif fused to a portion of a human antibody. The result is a potential therapeutic that can be easily delivered to patients. NeuroPhage has accumulated extensive preclinical data on this candidate, demonstrating its efficacy across disease models of Alzheimer's, Parkinson's and related diseases characterized by aggregation of the tau protein. NeuroPhage expects that NPT088 will be ready for human studies in late 2015.

"With recent advances in imaging agents for beta-amyloid and tau in Alzheimer's disease, we believe we should be able to demonstrate clinical proof of mechanism in a Phase 1b study with NPT088," said Jonathan Solomon, CEO at NeuroPhage. "If successful, we would then have the opportunity to pursue many therapeutic options in several neurodegenerative diseases of protein aggregation."

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Good News: TPUSA High School Clubs More Than Double, Hit 2,700 Nationwide

Atheist Bill Maher Condemns Media Silence on Christian Genocide in Nigeria: 'Systematic Killing'

'We Found Him': The Alleged Smoke Bomber Who Disrupted a Sean Feucht Worship Event; His Shocking Links to Antifa Inside Canada's Military

As Deadly Violence against Houses of Worship Rises, So Do Law Enforcement, Security Measures

Portland Police Arrest Conservative Journalist Nick Sortor Outside ICE Facility, 'But None of the Domestic Terrorists'

Apple Takes Down ICE Tracking Apps After Pressure from Bondi DOJ

Kash Patel's FBI Cuts All Ties to Southern Poverty Law Center

The President Is Already Using the Shutdown to Slash Federal Spending, Plans to Make Job Cuts

Israeli Leaders React to Terror Attack on UK Synagogue as Navy Intercepts Pro-Hamas Flotilla

President Trump Sets Sunday Deadline for Hamas to Accept Deal or Face 'ALL HELL'

'Blown Away': Hundreds Saved and Baptized as 8,000 Students Seek Jesus at University of Tennessee

Concerned Citizens Checked Their 'Conservative' Town High School Library for These Obscene Books Available to Students; Here's What Happened

DOJ Investigates Major School District Over DEI Programs

RFK Jr. Directs FDA to Study the Safety of Abortion Pills

Planned Parenthood Closes Houston Abortion Facility That Was Biggest in America

Democrat Prosecutor Sued after Dropping Charges against Woman Who Violently Assaulted Pro-Lifer

Kilmar Abrego Garcia's Final Order of Removal Stands as Judge Denies Motion to Reopen His Case

Gov't Shutdown Continues: White House Releases New Memo Exposing Dems' Demand for Nearly $200 B in Taxpayer-Funded Healthcare for Illegal Immigrants

Watch: Faith Revival Follows Charlie Kirk's Death As More People Attend Church and Read the Bible; 'This Is Bigger Than Charlie Kirk'

Israel's PM Just Blew Up All Those Conspiracy Theories About Charlie Kirk Being Anti-Semitic